Irene Chernova1, Namrata Krishnan2,3. 1. Yale School of Medicine/Section of Nephrology, New Haven, CT, USA. 2. Yale School of Medicine/Section of Nephrology, New Haven, CT, USA. Namrata.krishnan@yale.edu. 3. Veterans Affairs Medical Center, 950 Campbell Ave., West Haven, CT, 06516, USA. Namrata.krishnan@yale.edu.
Abstract
PURPOSE OF REVIEW: To discuss the current definition as well as recommendations for diagnosis and treatment of resistant hypertension (RH) based on the 2018 American Heart Association (AHA) guidelines and recent literature. RECENT FINDINGS: RH is defined as uncontrolled blood pressure (BP) on ≥ 3 anti-hypertensives, one of which should be a diuretic, prescribed at maximally tolerated doses and appropriate dosing frequency. The diagnosis of RH requires exclusion of white coat effect and medication non-adherence, underscoring the importance of out-of-office BP measurements. Secondary causes of hypertension must be excluded in all patients with RH. A step-wise approach to treatment focusing on lifestyle modifications and medication optimization can be effective in > 50% of the patients with RH. Device-based interventional therapies for RH are currently investigational. Out-of-office BP measurements are central to the diagnosis of RH. Medication optimization is successful in most patients. Further studies are needed to define the role of device-based interventions.
PURPOSE OF REVIEW: To discuss the current definition as well as recommendations for diagnosis and treatment of resistant hypertension (RH) based on the 2018 American Heart Association (AHA) guidelines and recent literature. RECENT FINDINGS: RH is defined as uncontrolled blood pressure (BP) on ≥ 3 anti-hypertensives, one of which should be a diuretic, prescribed at maximally tolerated doses and appropriate dosing frequency. The diagnosis of RH requires exclusion of white coat effect and medication non-adherence, underscoring the importance of out-of-office BP measurements. Secondary causes of hypertension must be excluded in all patients with RH. A step-wise approach to treatment focusing on lifestyle modifications and medication optimization can be effective in > 50% of the patients with RH. Device-based interventional therapies for RH are currently investigational. Out-of-office BP measurements are central to the diagnosis of RH. Medication optimization is successful in most patients. Further studies are needed to define the role of device-based interventions.
Entities:
Keywords:
Ambulatory BP monitoring; Hyperaldosteronism; Pseudoresistance; Renal denervation; Resistant hypertension; White coat hypertension
Authors: David A Calhoun; Mari K Nishizaka; Mohammad A Zaman; Roopal B Thakkar; Paula Weissmann Journal: Hypertension Date: 2002-12 Impact factor: 10.190
Authors: Anne L Taylor; Susan Ziesche; Clyde Yancy; Peter Carson; Ralph D'Agostino; Keith Ferdinand; Malcolm Taylor; Kirkwood Adams; Michael Sabolinski; Manuel Worcel; Jay N Cohn Journal: N Engl J Med Date: 2004-11-08 Impact factor: 91.245
Authors: Nieves Martell; Matilde Rodriguez-Cerrillo; D E Grobbee; M Dolores López-Eady; Carmen Fernández-Pinilla; Mario Avila; Arturo Fernández-Cruz; Manuel Luque Journal: Blood Press Date: 2003 Impact factor: 2.835